Literature DB >> 17696517

Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins.

Johan Ingvarsson1, Anette Larsson, Anders G Sjöholm, Lennart Truedsson, Bo Jansson, Carl A K Borrebaeck, Christer Wingren.   

Abstract

Antibody-based microarrays is a novel technology with great promise for high-throughput proteomics. The process of designing high-performing arrays has, however, turned out to be challenging. Here, we have designed the next generation of a human recombinant scFv antibody microarray platform for protein expression profiling of nonfractionated biotinylated human plasma and serum proteomes. The setup, based on black polymer Maxisorb slides interfaced with a fluorescent-based read-out system, was found to provide specific, sensitive (subpicomolar (pM) range) and reproducible means for protein profiling. Further, a chip-to-chip normalization protocol critical for comparing data generated on different chips was devised. Finally, the microarray data were found to correlate well with clinical laboratory data obtained using conventional methods, as demonstrated for a set of medium abundant (micromolar (microM) to nanomolar (nM) range) protein analytes in serum and plasma samples derived from healthy and complement-deficient individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696517     DOI: 10.1021/pr070204f

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  20 in total

Review 1.  New technologies in cancer. Protein microarrays for biomarker discovery.

Authors:  Sergio Matarraz; María González-González; María Jara; Alberto Orfao; Manuel Fuentes
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

2.  Applications of protein microarrays for biomarker discovery.

Authors:  Niroshan Ramachandran; Sanjeeva Srivastava; Joshua Labaer
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

3.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

4.  Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.

Authors:  Anders Carlsson; Dirk M Wuttge; Johan Ingvarsson; Anders A Bengtsson; Gunnar Sturfelt; Carl A K Borrebaeck; Christer Wingren
Journal:  Mol Cell Proteomics       Date:  2011-02-24       Impact factor: 5.911

5.  Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Authors:  Malin Nordström; Christer Wingren; Carsten Rose; Anders Bjartell; Charlotte Becker; Hans Lilja; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2014-10-22       Impact factor: 3.494

6.  Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarrays.

Authors:  M Centlow; C Wingren; C Borrebaeck; M J Brownstein; S R Hansson
Journal:  J Pregnancy       Date:  2011-03-08

7.  Assessment and optimisation of normalisation methods for dual-colour antibody microarrays.

Authors:  Martin Sill; Christoph Schröder; Jörg D Hoheisel; Axel Benner; Manuela Zucknick
Journal:  BMC Bioinformatics       Date:  2010-11-12       Impact factor: 3.169

8.  Identification of a serum biomarker signature associated with metastatic prostate cancer.

Authors:  Venera Kuci Emruli; Leena Liljedahl; Ulrika Axelsson; Corinna Richter; Lisa Theorin; Anders Bjartell; Hans Lilja; Jenny Donovan; David Neal; Freddie C Hamdy; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2021-05-04       Impact factor: 3.603

9.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

10.  Screening for C3 deficiency in newborns using microarrays.

Authors:  Magdalena Janzi; Ronald Sjöberg; Jinghong Wan; Björn Fischler; Ulrika von Döbeln; Lourdes Isaac; Peter Nilsson; Lennart Hammarström
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.